Determination of Corosolic Acid, a Natural Potential Anti-Diabetes Compound, in Rat Plasma by High-Performance Liquid Chromatography-Mass Spectrometry and its Application to Pharmacokinetic and Bioavailability Studies

Abstract

A simple, robust, and sensitive high-performance liquid chromatography/mass spectrometric method was developed for the determination of corosolic acid, a potential anti-diabetes substance, in rat plasma using glycyrrhetinic acid as the internal standard (IS). This method involved a liquid-liquid extraction with acetic ether and a subsequent analysis performed on an LC-MS system which contained an electrospray ionization interface. Chromatographic separation was performed using an ODS column, and the mobile phase was composed of methanol and 5 mmol/L ammonium acetate (88 : 12, v/v). Good linearity was observed over the concentration range of 20–10 000 ng/mL with a correlation coefficient (r²) ≥ 0.995. The method was proved to be accurate and reliable and was applied to a pharmacokinetic study in the rat following intragastric and intravenous administration of corosolic acid.

Key words

corosolic acid - HPLC-ESI-MS - anti-diabetes - pharmacokinetics - bioavailability

References

• 1 Xu Y, Ge R, Du J, Xin H, Yi T, Sheng J, Wang Y, Ling C. Corosolic acid induces apoptosis through mitochondrial pathway and caspase activation in human cervix adenocarcinoma HeLa cells.  Cancer Lett. 2009;  284 229-237
• 2 Suzuki Y, Unno T, Ushitani M, Hayashi K, Kakuda T. Antiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-Ay mice.  J Nutr Sci Vitaminol (Tokyo). 1999;  45 791-795
• 3 Garo E, Eldridge G R, Goering M G, DeLancey Pulcini E, Hamilton M A, Costerton J W, James G A. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.  Antimicrob Agents Chemother. 2007;  51 1813-1817
• 4 Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome.  Life Sci. 2006;  79 2474-2479
• 5 Shi L, Zhang W, Zhou Y Y, Zhang Y N, Li J Y, Hu L H, Li J. Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation.  Eur J Pharmacol. 2008;  584 21-29
• 6 Yamada K, Hosokawa M, Fujimoto S, Fujiwara H, Fujita Y, Harada N, Yamada C, Fukushima M, Ueda N, Kaneko T, Matsuyama F, Yamada Y, Seino Y, Inagaki N. Effect of corosolic acid on gluconeogenesis in rat liver.  Diabetes Res Clin Pract. 2008;  80 48-55
• 7 Yamada K, Hosokawa M, Yamada C, Watanabe R, Fujimoto S, Fujiwara H, Kunitomo M, Miura T, Kaneko T, Tsuda K, Seino Y, Inagaki N. Dietary corosolic acid ameliorates obesity and hepatic steatosis in KK-Ay mice.  Biol Pharm Bull. 2008;  31 651-655
• 8 Yamada K, Hosokawa M, Fujimoto S, Fujiwara H, Fujita Y, Harada N, Yamada C, Fukushima M, Ueda N, Kaneko T, Matsuyama F, Yamada Y, Seino Y, Inagaki N. Effect of corosolic acid on gluconeogenesis in rat liver.  Diabetes Res Clin Pract. 2008;  80 48-55
• 9 Miura T, Ueda N, Yamada K, Fukushima M, Ishida T, Kaneko T, Matsuyama F, Seino Y. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice.  Biol Pharm Bull. 2006;  29 585-587
• 10 Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y. Effect of corosolic acid on postchallenge plasma glucose levels.  Diabetes Res Clin Pract. 2006;  73 174-177
• 11 Jing J, Ren W, Chen X, Wang Y, Yu Q, Wang G, Davey A K, Wang J, Jing N. Glucuronide-sulfate diconjugate as a novel metabolite of glycyrrhetic acid in rat bile.  Drug Metab Pharmacokinet. 2008;  23 175-180
• 12 Lu Y, Zhu J, Chen X, Li N, Fu F, He J, Wang G, Zhang L, Zheng Y, Qiu Z, Yu X, Han D, Wu L. Identification of human UDP-glucuronosyltransferase isoforms responsible for the glucuronidation of glycyrrhetinic acid.  Drug Metab Pharmacokinet. 2009;  24 523-528